The price to earnings ratio is a measurement often used to determine stock valuation. In short, P/E is used to measure what the market is willing to pay for a company based on its earnings. The trailing P/E for biotechnology drugs companies operating in the healthcare products market was approximately 87.9. This meant that an investor would be willing to pay 87.9 dollars for every one dollar made through earnings.
Another formula that is used by investors to measure the value of an industry or potential target company for acquisition is the enterprise value to earnings before interest, taxes, depreciation and amortization (EV/EBITDA).
Trailing and forward price to earnings ratio (PE ratio) in the health & pharmaceuticals sector in Western Europe 2023, by industry
Characteristic
Trailing PE
Forward PE
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Leonard N. Stern School of Business. (January 5, 2023). Trailing and forward price to earnings ratio (PE ratio) in the health & pharmaceuticals sector in Western Europe 2023, by industry [Graph]. In Statista. Retrieved September 13, 2024, from https://www.statista.com/statistics/1028311/price-earnings-in-the-health-and-pharmaceuticals-sector-in-europe/
Leonard N. Stern School of Business. "Trailing and forward price to earnings ratio (PE ratio) in the health & pharmaceuticals sector in Western Europe 2023, by industry." Chart. January 5, 2023. Statista. Accessed September 13, 2024. https://www.statista.com/statistics/1028311/price-earnings-in-the-health-and-pharmaceuticals-sector-in-europe/
Leonard N. Stern School of Business. (2023). Trailing and forward price to earnings ratio (PE ratio) in the health & pharmaceuticals sector in Western Europe 2023, by industry. Statista. Statista Inc.. Accessed: September 13, 2024. https://www.statista.com/statistics/1028311/price-earnings-in-the-health-and-pharmaceuticals-sector-in-europe/
Leonard N. Stern School of Business. "Trailing and Forward Price to Earnings Ratio (Pe Ratio) in The Health & Pharmaceuticals Sector in Western Europe 2023, by Industry." Statista, Statista Inc., 5 Jan 2023, https://www.statista.com/statistics/1028311/price-earnings-in-the-health-and-pharmaceuticals-sector-in-europe/
Leonard N. Stern School of Business, Trailing and forward price to earnings ratio (PE ratio) in the health & pharmaceuticals sector in Western Europe 2023, by industry Statista, https://www.statista.com/statistics/1028311/price-earnings-in-the-health-and-pharmaceuticals-sector-in-europe/ (last visited September 13, 2024)
Trailing and forward price to earnings ratio (PE ratio) in the health & pharmaceuticals sector in Western Europe 2023, by industry [Graph], Leonard N. Stern School of Business, January 5, 2023. [Online]. Available: https://www.statista.com/statistics/1028311/price-earnings-in-the-health-and-pharmaceuticals-sector-in-europe/
